| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombospondin 1 | 90 | 2023 | 250 | 10.170 |
Why?
|
| Thrombospondins | 60 | 2014 | 198 | 3.600 |
Why?
|
| Neovascularization, Pathologic | 35 | 2022 | 2638 | 1.870 |
Why?
|
| Extracellular Matrix Proteins | 20 | 2011 | 850 | 1.860 |
Why?
|
| Angiogenesis Inhibitors | 24 | 2021 | 2038 | 1.520 |
Why?
|
| Glycoproteins | 29 | 2009 | 2266 | 1.440 |
Why?
|
| Platelet Membrane Glycoproteins | 11 | 1993 | 293 | 0.920 |
Why?
|
| Vascular Endothelial Growth Factor A | 12 | 2022 | 3511 | 0.890 |
Why?
|
| Transforming Growth Factor beta | 14 | 2014 | 2007 | 0.700 |
Why?
|
| Blood Platelets | 29 | 2005 | 2509 | 0.700 |
Why?
|
| Membrane Glycoproteins | 16 | 2001 | 3771 | 0.600 |
Why?
|
| Endothelial Cells | 15 | 2017 | 3486 | 0.550 |
Why?
|
| Cartilage | 7 | 2007 | 818 | 0.550 |
Why?
|
| Recombinant Proteins | 18 | 2014 | 6621 | 0.480 |
Why?
|
| Amino Acid Sequence | 41 | 2012 | 13814 | 0.480 |
Why?
|
| Molecular Sequence Data | 40 | 2012 | 18111 | 0.470 |
Why?
|
| Spectrin | 11 | 1990 | 177 | 0.470 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2012 | 547 | 0.460 |
Why?
|
| Heparin | 16 | 2008 | 1637 | 0.440 |
Why?
|
| Calcium Channels | 2 | 2014 | 622 | 0.430 |
Why?
|
| Protein Structure, Tertiary | 17 | 2011 | 3848 | 0.420 |
Why?
|
| Integrins | 6 | 2009 | 846 | 0.420 |
Why?
|
| Eye | 3 | 2015 | 729 | 0.410 |
Why?
|
| Endothelium, Vascular | 17 | 2009 | 4459 | 0.410 |
Why?
|
| Thyroid Neoplasms | 9 | 2023 | 2282 | 0.400 |
Why?
|
| Peptide Fragments | 27 | 2009 | 5096 | 0.380 |
Why?
|
| Neoplasms | 11 | 2022 | 21696 | 0.370 |
Why?
|
| Cell Adhesion Molecules | 10 | 1999 | 1602 | 0.370 |
Why?
|
| Mice | 84 | 2023 | 81201 | 0.360 |
Why?
|
| Calcium | 12 | 2014 | 5755 | 0.350 |
Why?
|
| Thrombin | 11 | 1998 | 598 | 0.350 |
Why?
|
| Animals | 117 | 2023 | 168768 | 0.350 |
Why?
|
| Eye Diseases | 1 | 2015 | 669 | 0.350 |
Why?
|
| Cell Movement | 14 | 2012 | 5218 | 0.350 |
Why?
|
| Receptors, Complement 3b | 1 | 2009 | 145 | 0.340 |
Why?
|
| Angiogenesis Modulating Agents | 1 | 2008 | 8 | 0.330 |
Why?
|
| Chondrocytes | 3 | 2005 | 804 | 0.320 |
Why?
|
| Elliptocytosis, Hereditary | 6 | 1990 | 30 | 0.320 |
Why?
|
| Aggrecans | 1 | 2007 | 90 | 0.300 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2011 | 1504 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 4 | 2013 | 1351 | 0.290 |
Why?
|
| Proto-Oncogene Proteins B-raf | 7 | 2023 | 2043 | 0.290 |
Why?
|
| Protein Binding | 24 | 2012 | 9384 | 0.280 |
Why?
|
| Gene Expression | 8 | 2004 | 7798 | 0.280 |
Why?
|
| Pericytes | 3 | 2023 | 293 | 0.280 |
Why?
|
| Binding Sites | 15 | 2011 | 6111 | 0.280 |
Why?
|
| Cell Adhesion | 15 | 2005 | 3144 | 0.270 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2006 | 156 | 0.260 |
Why?
|
| Sequence Alignment | 8 | 2011 | 2256 | 0.260 |
Why?
|
| Crystallography, X-Ray | 6 | 2011 | 2012 | 0.260 |
Why?
|
| Integrin beta Chains | 1 | 2005 | 121 | 0.250 |
Why?
|
| Signal Transduction | 18 | 2018 | 23404 | 0.250 |
Why?
|
| Mice, Knockout | 25 | 2017 | 14561 | 0.250 |
Why?
|
| Thrombosis | 3 | 2016 | 2968 | 0.250 |
Why?
|
| Endostatins | 4 | 2011 | 174 | 0.240 |
Why?
|
| Cells, Cultured | 30 | 2017 | 19233 | 0.240 |
Why?
|
| Membrane Proteins | 9 | 2014 | 7882 | 0.240 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2011 | 2455 | 0.230 |
Why?
|
| Ovarian Neoplasms | 5 | 2021 | 4839 | 0.230 |
Why?
|
| Oligopeptides | 9 | 2009 | 1189 | 0.230 |
Why?
|
| Cloning, Molecular | 14 | 2019 | 4320 | 0.230 |
Why?
|
| Indoles | 5 | 2016 | 1839 | 0.230 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 9 | 2005 | 798 | 0.220 |
Why?
|
| Neoplasms, Experimental | 4 | 2005 | 1276 | 0.220 |
Why?
|
| Cytoskeleton | 4 | 2000 | 1185 | 0.210 |
Why?
|
| Achondroplasia | 2 | 1998 | 26 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 2916 | 0.200 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3707 | 0.200 |
Why?
|
| Hyperplasia | 3 | 2016 | 1185 | 0.190 |
Why?
|
| Platelet Aggregation | 7 | 1998 | 798 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 25 | 2021 | 21833 | 0.190 |
Why?
|
| Erythrocytes, Abnormal | 5 | 1990 | 125 | 0.190 |
Why?
|
| Humans | 137 | 2023 | 744366 | 0.190 |
Why?
|
| Genetic Vectors | 5 | 2019 | 3424 | 0.190 |
Why?
|
| Chick Embryo | 5 | 1999 | 982 | 0.180 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 385 | 0.180 |
Why?
|
| Apoptosis | 16 | 2014 | 9724 | 0.180 |
Why?
|
| Protein Conformation | 14 | 2007 | 4010 | 0.180 |
Why?
|
| Molecular Weight | 15 | 1993 | 2255 | 0.180 |
Why?
|
| Multigene Family | 4 | 2001 | 1102 | 0.170 |
Why?
|
| Base Sequence | 15 | 2009 | 12797 | 0.170 |
Why?
|
| Quinazolines | 1 | 2006 | 1356 | 0.170 |
Why?
|
| Collagen Type IV | 3 | 2011 | 140 | 0.170 |
Why?
|
| Antineoplastic Agents | 8 | 2014 | 13693 | 0.170 |
Why?
|
| Polysaccharides | 1 | 2006 | 1059 | 0.170 |
Why?
|
| Glycosaminoglycans | 5 | 2009 | 624 | 0.170 |
Why?
|
| Erythrocyte Membrane | 8 | 1990 | 442 | 0.160 |
Why?
|
| Edetic Acid | 3 | 2007 | 275 | 0.160 |
Why?
|
| Trypsin | 9 | 1995 | 511 | 0.160 |
Why?
|
| Xenopus laevis | 5 | 1998 | 957 | 0.160 |
Why?
|
| Chemotaxis | 6 | 2011 | 607 | 0.160 |
Why?
|
| Crosses, Genetic | 4 | 2005 | 791 | 0.150 |
Why?
|
| Cell Line, Tumor | 17 | 2021 | 16690 | 0.150 |
Why?
|
| Microscopy, Electron | 12 | 2000 | 2646 | 0.150 |
Why?
|
| Antigens, CD | 3 | 2012 | 4026 | 0.150 |
Why?
|
| Disease Models, Animal | 15 | 2023 | 18034 | 0.150 |
Why?
|
| Cell Division | 11 | 2005 | 4569 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 17 | 2009 | 9274 | 0.150 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2017 | 56 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2012 | 2839 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 1991 | 1085 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 2 | 1995 | 1081 | 0.140 |
Why?
|
| Anemia, Hemolytic, Congenital | 2 | 1988 | 69 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 315 | 0.140 |
Why?
|
| 3T3 Cells | 4 | 1998 | 1101 | 0.140 |
Why?
|
| Crystallization | 2 | 2007 | 525 | 0.130 |
Why?
|
| Collagen | 9 | 2010 | 2688 | 0.130 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2016 | 194 | 0.130 |
Why?
|
| Mice, Transgenic | 10 | 2017 | 9735 | 0.130 |
Why?
|
| Muscles | 3 | 1998 | 1614 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2018 | 644 | 0.130 |
Why?
|
| Autoantigens | 3 | 2011 | 892 | 0.130 |
Why?
|
| Cell Proliferation | 10 | 2015 | 10483 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 2 | 2012 | 116 | 0.130 |
Why?
|
| Connective Tissue | 1 | 1997 | 420 | 0.120 |
Why?
|
| Mice, Mutant Strains | 3 | 2009 | 1865 | 0.120 |
Why?
|
| Oncolytic Viruses | 1 | 2018 | 327 | 0.120 |
Why?
|
| Sulfonamides | 3 | 2014 | 1940 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 906 | 0.120 |
Why?
|
| Umbilical Veins | 3 | 2011 | 433 | 0.120 |
Why?
|
| Tunica Intima | 1 | 2016 | 464 | 0.120 |
Why?
|
| Hemangiopericytoma | 1 | 2014 | 77 | 0.120 |
Why?
|
| Transfection | 8 | 2011 | 5895 | 0.120 |
Why?
|
| Proteoglycans | 3 | 1997 | 837 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4208 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 1723 | 0.120 |
Why?
|
| Immunohistochemistry | 12 | 2015 | 11366 | 0.120 |
Why?
|
| Finger Joint | 1 | 1994 | 108 | 0.110 |
Why?
|
| In Situ Hybridization | 8 | 2003 | 1950 | 0.110 |
Why?
|
| Islets of Langerhans | 2 | 2011 | 1352 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2014 | 5181 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2013 | 70 | 0.110 |
Why?
|
| Oncolytic Virotherapy | 1 | 2018 | 498 | 0.110 |
Why?
|
| Genes | 3 | 1993 | 1893 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 2949 | 0.110 |
Why?
|
| von Willebrand Factor | 3 | 2006 | 669 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2018 | 3554 | 0.110 |
Why?
|
| Pneumonia | 3 | 2010 | 2133 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2014 | 664 | 0.110 |
Why?
|
| Joint Prosthesis | 1 | 1994 | 258 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 475 | 0.100 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 2204 | 0.100 |
Why?
|
| Cell Membrane | 3 | 2012 | 3749 | 0.100 |
Why?
|
| Blood Proteins | 7 | 1996 | 1124 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2016 | 950 | 0.100 |
Why?
|
| RNA, Messenger | 14 | 2015 | 13035 | 0.100 |
Why?
|
| Drosophila | 2 | 2011 | 1491 | 0.100 |
Why?
|
| Extracellular Matrix | 6 | 2009 | 1741 | 0.100 |
Why?
|
| Mice, Nude | 7 | 2013 | 3689 | 0.100 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 964 | 0.100 |
Why?
|
| Calreticulin | 1 | 2012 | 98 | 0.100 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 365 | 0.100 |
Why?
|
| Lectins | 2 | 1991 | 513 | 0.100 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2012 | 177 | 0.100 |
Why?
|
| Restriction Mapping | 5 | 1998 | 878 | 0.100 |
Why?
|
| Histamine | 1 | 2013 | 507 | 0.100 |
Why?
|
| Retinal Vessels | 2 | 2009 | 772 | 0.100 |
Why?
|
| Up-Regulation | 5 | 2015 | 4222 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2004 | 4034 | 0.100 |
Why?
|
| Blindness | 1 | 2015 | 615 | 0.100 |
Why?
|
| Inflammation | 6 | 2015 | 10637 | 0.090 |
Why?
|
| Peptides | 9 | 2011 | 4410 | 0.090 |
Why?
|
| Mutation | 12 | 2014 | 29786 | 0.090 |
Why?
|
| Chagas Disease | 1 | 2012 | 166 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 9 | 2003 | 1801 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2021 | 4561 | 0.090 |
Why?
|
| Disulfides | 2 | 2011 | 457 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2008 | 20824 | 0.090 |
Why?
|
| Receptors, Cytoadhesin | 1 | 1989 | 8 | 0.090 |
Why?
|
| Trypanosoma cruzi | 1 | 2012 | 197 | 0.090 |
Why?
|
| Blotting, Northern | 5 | 2003 | 1581 | 0.090 |
Why?
|
| Disease Progression | 6 | 2011 | 13286 | 0.090 |
Why?
|
| Thrombasthenia | 1 | 1989 | 24 | 0.090 |
Why?
|
| Neoplasm Transplantation | 4 | 2014 | 2086 | 0.090 |
Why?
|
| Kinetics | 7 | 2007 | 6476 | 0.090 |
Why?
|
| Smad2 Protein | 2 | 2010 | 156 | 0.090 |
Why?
|
| Glycosylation | 2 | 2011 | 1128 | 0.090 |
Why?
|
| Serotonin | 2 | 2013 | 1017 | 0.090 |
Why?
|
| Capillary Permeability | 2 | 2013 | 798 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2009 | 5451 | 0.090 |
Why?
|
| Dimerization | 2 | 2008 | 895 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 687 | 0.090 |
Why?
|
| Endothelium | 6 | 1992 | 778 | 0.090 |
Why?
|
| Blood Platelet Disorders | 1 | 1989 | 58 | 0.080 |
Why?
|
| Dependovirus | 2 | 2019 | 706 | 0.080 |
Why?
|
| Collagen Type IX | 1 | 2008 | 20 | 0.080 |
Why?
|
| Arthritis | 1 | 1994 | 661 | 0.080 |
Why?
|
| Chromatography, Gel | 2 | 2007 | 668 | 0.080 |
Why?
|
| Spinal Cord | 1 | 1997 | 1810 | 0.080 |
Why?
|
| Static Electricity | 1 | 2009 | 263 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 988 | 0.080 |
Why?
|
| Phosphorylation | 5 | 2011 | 8436 | 0.080 |
Why?
|
| Platelet Activation | 1 | 1992 | 674 | 0.080 |
Why?
|
| Osteogenesis | 1 | 1995 | 1299 | 0.080 |
Why?
|
| Proteins | 4 | 1998 | 6100 | 0.080 |
Why?
|
| Down-Regulation | 4 | 2015 | 3001 | 0.080 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2005 | 111 | 0.080 |
Why?
|
| Synapses | 2 | 2009 | 1728 | 0.080 |
Why?
|
| Mice, SCID | 6 | 2011 | 2716 | 0.080 |
Why?
|
| Chymotrypsin | 2 | 1994 | 149 | 0.080 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2009 | 104 | 0.080 |
Why?
|
| Fibronectins | 6 | 1999 | 726 | 0.070 |
Why?
|
| Structure-Activity Relationship | 6 | 2002 | 3130 | 0.070 |
Why?
|
| Corneal Neovascularization | 2 | 2011 | 188 | 0.070 |
Why?
|
| Melanoma, Experimental | 2 | 2001 | 561 | 0.070 |
Why?
|
| Chondroitin Sulfates | 1 | 2007 | 187 | 0.070 |
Why?
|
| Receptor, TIE-2 | 2 | 2005 | 178 | 0.070 |
Why?
|
| Carcinoma | 3 | 2010 | 2375 | 0.070 |
Why?
|
| Cell Line | 7 | 2014 | 16000 | 0.070 |
Why?
|
| Hyperoxia | 1 | 2009 | 262 | 0.070 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 353 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2011 | 745 | 0.070 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2008 | 266 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2009 | 2050 | 0.070 |
Why?
|
| Receptors, Vitronectin | 2 | 1999 | 52 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 5 | 2011 | 5263 | 0.070 |
Why?
|
| Tissue Distribution | 4 | 1998 | 2327 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2005 | 347 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2008 | 1247 | 0.070 |
Why?
|
| Bone and Bones | 4 | 2008 | 2576 | 0.070 |
Why?
|
| Concanavalin A | 1 | 2006 | 191 | 0.070 |
Why?
|
| Heparan Sulfate Proteoglycans | 2 | 2004 | 118 | 0.070 |
Why?
|
| Structural Homology, Protein | 1 | 2006 | 91 | 0.070 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 530 | 0.070 |
Why?
|
| Cell Survival | 6 | 2018 | 5882 | 0.070 |
Why?
|
| Plant Lectins | 1 | 1986 | 104 | 0.070 |
Why?
|
| Cattle | 9 | 2003 | 3922 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2006 | 180 | 0.070 |
Why?
|
| Cysteine | 2 | 2009 | 873 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 2850 | 0.070 |
Why?
|
| Protein Folding | 3 | 2011 | 840 | 0.070 |
Why?
|
| Macromolecular Substances | 5 | 1992 | 1454 | 0.070 |
Why?
|
| Integrin alpha5beta1 | 1 | 2005 | 38 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 9 | 2005 | 6313 | 0.070 |
Why?
|
| Heterozygote | 3 | 2006 | 2804 | 0.060 |
Why?
|
| Platelet Adhesiveness | 1 | 2005 | 161 | 0.060 |
Why?
|
| Polyomavirus | 1 | 2006 | 249 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 10943 | 0.060 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 6773 | 0.060 |
Why?
|
| Models, Biological | 5 | 2018 | 9584 | 0.060 |
Why?
|
| Solubility | 4 | 2001 | 1088 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 5172 | 0.060 |
Why?
|
| Thrombocythemia, Essential | 1 | 1986 | 105 | 0.060 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 694 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2009 | 2504 | 0.060 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2005 | 96 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2007 | 4925 | 0.060 |
Why?
|
| Staining and Labeling | 3 | 2012 | 1101 | 0.060 |
Why?
|
| Phylogeny | 3 | 1999 | 2804 | 0.060 |
Why?
|
| Receptors, LDL | 1 | 2007 | 476 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2011 | 1915 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2000 | 313 | 0.060 |
Why?
|
| Erythrocytes | 6 | 1999 | 2455 | 0.060 |
Why?
|
| Serine Endopeptidases | 2 | 2008 | 1073 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2005 | 625 | 0.060 |
Why?
|
| Quinazolinones | 1 | 2006 | 221 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 1996 | 2865 | 0.060 |
Why?
|
| Isoelectric Focusing | 4 | 1985 | 181 | 0.060 |
Why?
|
| Lymphokines | 3 | 2003 | 949 | 0.060 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2004 | 42 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 396 | 0.060 |
Why?
|
| Female | 36 | 2021 | 380193 | 0.060 |
Why?
|
| Stomach Diseases | 1 | 2005 | 134 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2004 | 3773 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2009 | 1355 | 0.060 |
Why?
|
| Hematologic Diseases | 2 | 1990 | 498 | 0.060 |
Why?
|
| Antibodies | 1 | 1992 | 2460 | 0.060 |
Why?
|
| Genital Diseases, Female | 1 | 2005 | 197 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 892 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2003 | 634 | 0.060 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2005 | 236 | 0.060 |
Why?
|
| Ligands | 2 | 2009 | 3282 | 0.060 |
Why?
|
| Macrophages | 3 | 2011 | 5660 | 0.060 |
Why?
|
| RNA Interference | 4 | 2017 | 2890 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2001 | 137 | 0.060 |
Why?
|
| Epithelial Cells | 3 | 2009 | 3690 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2132 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2005 | 644 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2009 | 838 | 0.050 |
Why?
|
| Iris | 1 | 2004 | 239 | 0.050 |
Why?
|
| Forecasting | 1 | 2012 | 2951 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2006 | 592 | 0.050 |
Why?
|
| DNA | 7 | 1998 | 7294 | 0.050 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 1999 | 95 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 1939 | 0.050 |
Why?
|
| Fibrinogen | 5 | 1996 | 894 | 0.050 |
Why?
|
| Methods | 1 | 2003 | 1129 | 0.050 |
Why?
|
| Immunoassay | 3 | 2005 | 752 | 0.050 |
Why?
|
| Genes, APC | 1 | 2003 | 159 | 0.050 |
Why?
|
| Central Nervous System | 2 | 2005 | 1357 | 0.050 |
Why?
|
| Vascular Diseases | 2 | 2007 | 1161 | 0.050 |
Why?
|
| Luciferases | 1 | 2004 | 733 | 0.050 |
Why?
|
| Iodine Radioisotopes | 2 | 2023 | 1032 | 0.050 |
Why?
|
| Ovary | 1 | 2007 | 981 | 0.050 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 2 | 2014 | 59 | 0.050 |
Why?
|
| Teratocarcinoma | 1 | 2001 | 17 | 0.050 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3590 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 574 | 0.050 |
Why?
|
| Integrin alpha6beta1 | 1 | 2001 | 18 | 0.050 |
Why?
|
| Cholic Acids | 1 | 2001 | 41 | 0.050 |
Why?
|
| Chondrogenesis | 1 | 2003 | 247 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3255 | 0.050 |
Why?
|
| Lung | 3 | 2005 | 9857 | 0.050 |
Why?
|
| Beta-Globulins | 1 | 1981 | 27 | 0.050 |
Why?
|
| beta-Thromboglobulin | 1 | 1981 | 24 | 0.050 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2001 | 114 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2566 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 4751 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3873 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2005 | 826 | 0.050 |
Why?
|
| Cyclophosphamide | 2 | 2004 | 2242 | 0.050 |
Why?
|
| Fibrinolysin | 1 | 1981 | 131 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 13104 | 0.050 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2014 | 197 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1115 | 0.050 |
Why?
|
| Phenotype | 5 | 2005 | 16367 | 0.050 |
Why?
|
| Genes, p53 | 2 | 2009 | 755 | 0.050 |
Why?
|
| Alopecia | 1 | 2005 | 382 | 0.050 |
Why?
|
| Valine | 2 | 2014 | 413 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2003 | 208 | 0.050 |
Why?
|
| Cornea | 4 | 2011 | 1524 | 0.050 |
Why?
|
| Detergents | 1 | 2001 | 230 | 0.050 |
Why?
|
| Platelet Factor 4 | 1 | 1981 | 129 | 0.050 |
Why?
|
| Mammary Arteries | 1 | 2001 | 70 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2943 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8432 | 0.050 |
Why?
|
| Mannose | 1 | 2000 | 124 | 0.050 |
Why?
|
| Blood Vessels | 2 | 1998 | 1125 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 984 | 0.050 |
Why?
|
| Fucose | 1 | 2000 | 126 | 0.050 |
Why?
|
| Chemistry | 3 | 1987 | 352 | 0.050 |
Why?
|
| Epithelium | 1 | 2005 | 1679 | 0.050 |
Why?
|
| Epitopes | 4 | 1996 | 2571 | 0.050 |
Why?
|
| Exons | 2 | 1999 | 2439 | 0.040 |
Why?
|
| Mesoderm | 1 | 2003 | 686 | 0.040 |
Why?
|
| Chemical Phenomena | 3 | 1987 | 518 | 0.040 |
Why?
|
| Neutrophils | 3 | 2009 | 3721 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2001 | 258 | 0.040 |
Why?
|
| Parvovirinae | 1 | 2019 | 9 | 0.040 |
Why?
|
| Colitis | 1 | 2008 | 1170 | 0.040 |
Why?
|
| Species Specificity | 2 | 1994 | 2478 | 0.040 |
Why?
|
| Endocytosis | 1 | 2004 | 985 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2014 | 3481 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 587 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2001 | 684 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5867 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2008 | 4851 | 0.040 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 1999 | 153 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 4740 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2019 | 425 | 0.040 |
Why?
|
| Rats | 8 | 2009 | 24252 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 1981 | 355 | 0.040 |
Why?
|
| Hemosiderin | 1 | 1998 | 43 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 1985 | 2513 | 0.040 |
Why?
|
| Notochord | 1 | 1998 | 36 | 0.040 |
Why?
|
| Laminin | 2 | 1993 | 419 | 0.040 |
Why?
|
| Genetic Variation | 4 | 1988 | 6542 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1999 | 403 | 0.040 |
Why?
|
| Retina | 1 | 2009 | 2616 | 0.040 |
Why?
|
| Cardiomyopathies | 2 | 2012 | 1912 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2700 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 4 | 1994 | 2505 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 402 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 6386 | 0.040 |
Why?
|
| Piperidines | 1 | 2006 | 1602 | 0.040 |
Why?
|
| Graft Survival | 1 | 2008 | 3737 | 0.040 |
Why?
|
| Genotype | 3 | 2014 | 12952 | 0.040 |
Why?
|
| Erythropoiesis | 3 | 1988 | 706 | 0.040 |
Why?
|
| Enzyme Activation | 4 | 2009 | 3702 | 0.040 |
Why?
|
| Lordosis | 1 | 1998 | 84 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 17446 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 1998 | 183 | 0.040 |
Why?
|
| Caspases | 2 | 2014 | 928 | 0.040 |
Why?
|
| Astrocytes | 1 | 2005 | 1273 | 0.040 |
Why?
|
| Ribonucleases | 1 | 1998 | 287 | 0.040 |
Why?
|
| Longevity | 1 | 2005 | 1071 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 2542 | 0.040 |
Why?
|
| Biological Evolution | 2 | 1994 | 1077 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2014 | 1169 | 0.040 |
Why?
|
| Microcirculation | 3 | 2008 | 1287 | 0.040 |
Why?
|
| Heat-Shock Proteins | 2 | 1993 | 822 | 0.040 |
Why?
|
| Male | 23 | 2016 | 350115 | 0.040 |
Why?
|
| Neural Crest | 1 | 1999 | 275 | 0.040 |
Why?
|
| Introns | 1 | 1999 | 992 | 0.040 |
Why?
|
| Culture Media, Conditioned | 3 | 2005 | 537 | 0.040 |
Why?
|
| Plasmodium falciparum | 3 | 1999 | 1732 | 0.040 |
Why?
|
| Viscera | 1 | 1997 | 139 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 3799 | 0.040 |
Why?
|
| Elastin | 1 | 1998 | 308 | 0.030 |
Why?
|
| Regeneration | 1 | 2005 | 1485 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 1999 | 4805 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1998 | 348 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2015 | 36 | 0.030 |
Why?
|
| Plasminogen | 2 | 1986 | 152 | 0.030 |
Why?
|
| Cell Communication | 2 | 2005 | 1621 | 0.030 |
Why?
|
| Gene Expression Regulation | 7 | 2010 | 12073 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1985 | 3390 | 0.030 |
Why?
|
| Fibroblasts | 5 | 2004 | 4162 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2023 | 5534 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 772 | 0.030 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1995 | 70 | 0.030 |
Why?
|
| Hot Temperature | 3 | 1993 | 1356 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 9445 | 0.030 |
Why?
|
| Muridae | 1 | 1994 | 61 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1996 | 336 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 2001 | 806 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4463 | 0.030 |
Why?
|
| Cathepsins | 1 | 1996 | 241 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2015 | 236 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 1997 | 388 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4554 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1995 | 803 | 0.030 |
Why?
|
| Interferons | 1 | 2018 | 706 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2014 | 122 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2005 | 1887 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1998 | 550 | 0.030 |
Why?
|
| Nervous System | 1 | 1998 | 554 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6171 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 1994 | 166 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2018 | 541 | 0.030 |
Why?
|
| Actins | 2 | 1994 | 2121 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8642 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1994 | 84 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2006 | 11718 | 0.030 |
Why?
|
| Hand Deformities, Acquired | 1 | 1994 | 36 | 0.030 |
Why?
|
| Surface Properties | 2 | 2008 | 1184 | 0.030 |
Why?
|
| Colon | 2 | 2015 | 1772 | 0.030 |
Why?
|
| Chromatography, Affinity | 4 | 1997 | 549 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1998 | 1588 | 0.030 |
Why?
|
| CHO Cells | 3 | 2007 | 1409 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1998 | 1154 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 970 | 0.030 |
Why?
|
| Gene Library | 3 | 1991 | 1074 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1995 | 682 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2015 | 376 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1994 | 367 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1227 | 0.030 |
Why?
|
| Growth Substances | 2 | 1988 | 784 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 1092 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 2649 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2428 | 0.030 |
Why?
|
| Eosinophils | 1 | 1998 | 955 | 0.030 |
Why?
|
| Melanoma | 3 | 2001 | 5511 | 0.030 |
Why?
|
| Cricetinae | 3 | 2007 | 2475 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 1998 | 1152 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2012 | 1683 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 1998 | 707 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1998 | 1586 | 0.030 |
Why?
|
| Time Factors | 7 | 2009 | 40075 | 0.030 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2012 | 28 | 0.030 |
Why?
|
| Syndecans | 1 | 1992 | 79 | 0.030 |
Why?
|
| Leukocytes | 2 | 1994 | 2045 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2014 | 892 | 0.030 |
Why?
|
| Adenoma | 1 | 2003 | 2174 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 1998 | 5023 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 503 | 0.030 |
Why?
|
| Life Cycle Stages | 1 | 2012 | 160 | 0.020 |
Why?
|
| Chromones | 1 | 2011 | 154 | 0.020 |
Why?
|
| Stem Cells | 1 | 2005 | 3567 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2005 | 11486 | 0.020 |
Why?
|
| Wound Healing | 1 | 2002 | 2785 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 1991 | 378 | 0.020 |
Why?
|
| Microvessels | 1 | 2015 | 544 | 0.020 |
Why?
|
| Chickens | 1 | 1993 | 865 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2011 | 126 | 0.020 |
Why?
|
| Propionates | 1 | 2011 | 169 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 11031 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2010 | 96 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 399 | 0.020 |
Why?
|
| Brain | 1 | 1997 | 26388 | 0.020 |
Why?
|
| Survival Rate | 1 | 2004 | 12788 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2003 | 285 | 0.020 |
Why?
|
| Vimentin | 1 | 1990 | 262 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 480 | 0.020 |
Why?
|
| Gene Deletion | 3 | 2004 | 2751 | 0.020 |
Why?
|
| Bleomycin | 1 | 2010 | 512 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 489 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2009 | 115 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2009 | 148 | 0.020 |
Why?
|
| Skin | 4 | 2009 | 4372 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2009 | 195 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2009 | 141 | 0.020 |
Why?
|
| Amides | 1 | 2011 | 459 | 0.020 |
Why?
|
| Flavonoids | 1 | 2011 | 443 | 0.020 |
Why?
|
| Necrosis | 2 | 2005 | 1643 | 0.020 |
Why?
|
| Monocytes | 1 | 1998 | 2596 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2009 | 216 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11525 | 0.020 |
Why?
|
| Morpholines | 1 | 2011 | 571 | 0.020 |
Why?
|
| Coculture Techniques | 2 | 2005 | 1341 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2009 | 409 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2009 | 240 | 0.020 |
Why?
|
| Amines | 1 | 2009 | 276 | 0.020 |
Why?
|
| Spherocytosis, Hereditary | 1 | 1988 | 80 | 0.020 |
Why?
|
| Uterus | 1 | 1992 | 711 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 1012 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1828 | 0.020 |
Why?
|
| Hemolysis | 1 | 1989 | 420 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 1994 | 1578 | 0.020 |
Why?
|
| Culture Media | 2 | 1988 | 909 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 3505 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 560 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2018 | 63107 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 2008 | 163 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1401 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 577 | 0.020 |
Why?
|
| Homeostasis | 1 | 1998 | 3339 | 0.020 |
Why?
|
| Radiography | 1 | 1998 | 7023 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1986 | 80 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 758 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 15520 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 1988 | 193 | 0.020 |
Why?
|
| Granulosa Cells | 1 | 2007 | 121 | 0.020 |
Why?
|
| Adenosine Diphosphate | 2 | 1979 | 425 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 3617 | 0.020 |
Why?
|
| Cell Death | 2 | 2005 | 1707 | 0.020 |
Why?
|
| Tubulin | 1 | 1990 | 695 | 0.020 |
Why?
|
| Growth Plate | 1 | 2008 | 274 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4424 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 1998 | 3107 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 927 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 8300 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2009 | 551 | 0.020 |
Why?
|
| Circular Dichroism | 2 | 1983 | 354 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1998 | 3461 | 0.020 |
Why?
|
| Calcimycin | 1 | 2005 | 222 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3130 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1793 | 0.020 |
Why?
|
| Ionophores | 1 | 2005 | 108 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2007 | 3493 | 0.020 |
Why?
|
| Capillaries | 1 | 2009 | 773 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1992 | 1423 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 2 | 1990 | 1364 | 0.020 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1985 | 131 | 0.020 |
Why?
|
| Aorta | 3 | 2005 | 2062 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 2005 | 110 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2010 | 783 | 0.020 |
Why?
|
| DNA Primers | 2 | 2004 | 2891 | 0.020 |
Why?
|
| Ovarian Follicle | 1 | 2007 | 248 | 0.020 |
Why?
|
| Collagen Type XVIII | 1 | 2005 | 56 | 0.020 |
Why?
|
| Imidazoles | 1 | 2011 | 1206 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 818 | 0.020 |
Why?
|
| Oxygen | 2 | 2009 | 4189 | 0.020 |
Why?
|
| Integrin alpha3beta1 | 1 | 2004 | 53 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1989 | 1663 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2005 | 128 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 1988 | 640 | 0.020 |
Why?
|
| Edema | 1 | 2009 | 789 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1988 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2008 | 354 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2005 | 122 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1988 | 934 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 1999 | 599 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2005 | 5974 | 0.020 |
Why?
|
| Integrin alpha4beta1 | 1 | 2004 | 121 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 292 | 0.020 |
Why?
|
| Liposomes | 1 | 1988 | 759 | 0.020 |
Why?
|
| Antithrombins | 1 | 1987 | 304 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 1632 | 0.010 |
Why?
|
| Erythropoietin | 2 | 1985 | 726 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 2004 | 126 | 0.010 |
Why?
|
| Heme | 1 | 1985 | 307 | 0.010 |
Why?
|
| Cytokines | 1 | 2018 | 7323 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 2003 | 2383 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2726 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2009 | 1121 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 972 | 0.010 |
Why?
|
| Blood | 1 | 1985 | 598 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 712 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 743 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 845 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 302 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 2009 | 1173 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 2216 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1985 | 675 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 677 | 0.010 |
Why?
|
| Tretinoin | 1 | 2005 | 517 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1988 | 942 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 1986 | 545 | 0.010 |
Why?
|
| Phospholipids | 1 | 1985 | 784 | 0.010 |
Why?
|
| Dipeptides | 1 | 2004 | 409 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2088 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 640 | 0.010 |
Why?
|
| Biological Assay | 1 | 2005 | 652 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 391 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1995 | 2184 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2003 | 350 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2008 | 1539 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1981 | 240 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 1423 | 0.010 |
Why?
|
| Pedigree | 2 | 1990 | 4642 | 0.010 |
Why?
|
| Chemokines | 1 | 2005 | 970 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 2008 | 1095 | 0.010 |
Why?
|
| Proteinuria | 1 | 2004 | 658 | 0.010 |
Why?
|
| Zebrafish | 1 | 2012 | 2996 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 11126 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1993 | 306 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2000 | 263 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2000 | 225 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1996 | 1157 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1802 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 3912 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 697 | 0.010 |
Why?
|
| Vitronectin | 1 | 1999 | 44 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 5692 | 0.010 |
Why?
|
| Isoantibodies | 1 | 2004 | 679 | 0.010 |
Why?
|
| Extraembryonic Membranes | 1 | 1999 | 41 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 2825 | 0.010 |
Why?
|
| Batroxobin | 1 | 1979 | 3 | 0.010 |
Why?
|
| Adult | 9 | 2012 | 214052 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2011 | 2943 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1978 | 163 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1999 | 120 | 0.010 |
Why?
|
| Alkylation | 1 | 1978 | 86 | 0.010 |
Why?
|
| Reticulocytes | 2 | 1990 | 290 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1999 | 182 | 0.010 |
Why?
|
| Ankyrins | 2 | 1990 | 128 | 0.010 |
Why?
|
| Myocardium | 1 | 1992 | 4772 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2005 | 878 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 322 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 156 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1998 | 178 | 0.010 |
Why?
|
| Heart | 1 | 1992 | 4464 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 1026 | 0.010 |
Why?
|
| Inositol Phosphates | 1 | 1998 | 180 | 0.010 |
Why?
|
| Acute Disease | 1 | 2009 | 7147 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10252 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 937 | 0.010 |
Why?
|
| Decorin | 1 | 1997 | 40 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 1998 | 6486 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2003 | 838 | 0.010 |
Why?
|
| RNA | 2 | 2003 | 2749 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2000 | 675 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 2003 | 684 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 2076 | 0.010 |
Why?
|
| Cell Size | 1 | 1999 | 643 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1999 | 595 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 2016 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1976 | 115 | 0.010 |
Why?
|
| Cathepsin G | 1 | 1996 | 32 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 1996 | 64 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1976 | 172 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 1997 | 225 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2219 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 1996 | 90 | 0.010 |
Why?
|
| Sulfites | 1 | 1976 | 78 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1678 | 0.010 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 1996 | 94 | 0.010 |
Why?
|
| Liver | 1 | 1992 | 7475 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 9240 | 0.010 |
Why?
|
| Glucose | 1 | 2008 | 4398 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 3914 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 6896 | 0.010 |
Why?
|
| Peroxidase | 1 | 1998 | 611 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1677 | 0.010 |
Why?
|
| Properdin | 1 | 1994 | 31 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2938 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 6933 | 0.010 |
Why?
|
| Ischemia | 1 | 2003 | 1907 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1998 | 895 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1998 | 1472 | 0.010 |
Why?
|
| Procollagen | 1 | 1994 | 185 | 0.010 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1976 | 426 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1979 | 1060 | 0.010 |
Why?
|
| Tyramine | 1 | 1993 | 52 | 0.010 |
Why?
|
| Middle Aged | 4 | 2012 | 213390 | 0.010 |
Why?
|
| Apyrase | 1 | 1976 | 364 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1993 | 209 | 0.010 |
Why?
|
| Insulin | 1 | 2008 | 6582 | 0.010 |
Why?
|
| Antithrombin III | 1 | 1993 | 128 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1995 | 626 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 6254 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1999 | 1701 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1979 | 1127 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 1917 | 0.010 |
Why?
|
| Amino Acids | 1 | 1978 | 1737 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 39052 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 3514 | 0.010 |
Why?
|
| Osteoblasts | 1 | 1997 | 1166 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7184 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1994 | 15297 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1976 | 2556 | 0.010 |
Why?
|
| Rabbits | 1 | 1998 | 4894 | 0.010 |
Why?
|
| Pancreas | 1 | 1998 | 1687 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1995 | 1264 | 0.010 |
Why?
|
| Sodium | 1 | 1976 | 1622 | 0.010 |
Why?
|
| Malaria, Falciparum | 1 | 1999 | 1077 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1995 | 1525 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2000 | 2158 | 0.010 |
Why?
|
| Child | 3 | 1990 | 77709 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 9340 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1990 | 253 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 21748 | 0.000 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1988 | 102 | 0.000 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 1989 | 131 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1987 | 75 | 0.000 |
Why?
|
| Dactinomycin | 1 | 1988 | 318 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1988 | 356 | 0.000 |
Why?
|
| Drug Stability | 1 | 1988 | 291 | 0.000 |
Why?
|
| Thermolysin | 1 | 1986 | 14 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 219 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1986 | 124 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1987 | 919 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10183 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 4185 | 0.000 |
Why?
|
| Recurrence | 1 | 1998 | 8340 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 56429 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1990 | 41005 | 0.000 |
Why?
|
| Homozygote | 1 | 1990 | 1787 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14723 | 0.000 |
Why?
|
| Acetylation | 1 | 1988 | 1084 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2308 | 0.000 |
Why?
|
| Adolescent | 3 | 1990 | 85779 | 0.000 |
Why?
|
| Infant | 1 | 1985 | 35134 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1988 | 1460 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 8949 | 0.000 |
Why?
|
| Viscosity | 1 | 1981 | 328 | 0.000 |
Why?
|
| Aged | 1 | 2012 | 163288 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1988 | 1889 | 0.000 |
Why?
|
| Risk Factors | 1 | 2006 | 72296 | 0.000 |
Why?
|
| Fetus | 1 | 1986 | 1880 | 0.000 |
Why?
|
| Cholesterol | 1 | 1988 | 2919 | 0.000 |
Why?
|
| Lipids | 1 | 1988 | 3307 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1989 | 4397 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1989 | 4251 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1988 | 7721 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1987 | 25628 | 0.000 |
Why?
|